Marinovic J, Ljubkovic M, Stadnicka A, Bosnjak ZJ, Bienengraeber M. Role of sarcolemmal ATP-sensitive potassium channel in oxidative stress-induced apoptosis: mitochondrial connection. Am J Physiol Heart Circ Physiol 294: H1317-H1325, 2008. First published January 11, 2008 doi:10.1152/ajpheart.00840.2007.-From time of their discovery, sarcolemmal ATP-sensitive K ϩ (sarcKATP) channels were thought to have an important protective role in the heart during stress whereby channel opening protects the heart from stress-induced Ca 2ϩ overload and resulting damage. In contrast, some recent studies indicate that sarcKATP channel closing can lead to cardiac protection. Also, the role of the sarcKATP channel in apoptotic cell death is unclear. In the present study, the effects of channel inhibition on apoptosis and the specific interaction between the sarcKATP channel and mitochondria were investigated. Apoptotic cell death of cultured HL-1 and neonatal cardiomyocytes following exposure to oxidative stress was significantly increased in the presence of sarcKATP channel inhibitor HMR-1098 as evidenced by terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling and caspase-3,7 assays. This was paralleled by an increased release of cytochrome c from mitochondria to cytosol, suggesting activation of the mitochondrial death pathway. sarcKATP channel inhibition during stress had no effect on Bcl-2, Bad, and phospho-Bad, indicating that the increase in apoptosis cannot be attributed to these modulators of the apoptotic pathway. However, monitoring of mitochondrial Ca 2ϩ with rhod-2 fluorescent indicator revealed that mitochondrial Ca 2ϩ accumulation during stress is potentiated in the presence of HMR-1098. In conclusion, this study provides novel evidence that opening of sarcKATP channels, through a specific Ca 2ϩ -related interaction with mitochondria, plays an important role in preventing cardiomyocyte apoptosis and mitochondrial damage during stress. cardioprotection; mitochondrial calcium; cardiomyocytes THE ATP-SENSITIVE K ϩ (K ATP ) channels, first discovered in the heart more than 20 years ago, represent a unique group of channels that are regulated predominantly by the cellular metabolic state (32). The function of the cardiac sarcolemmal K ATP channel (sarcK ATP ) from early on was associated with cardiac response to stress (32), which was later confirmed by a number of studies. Opening of sarcK ATP channels during metabolic stress affects excitability and other membrane potential-related functions such as Ca 2ϩ loading, thus helping to maintain cellular homeostasis during cardiac challenge (13, 32).
cardioprotection; mitochondrial calcium; cardiomyocytes THE ATP-SENSITIVE K ϩ (K ATP ) channels, first discovered in the heart more than 20 years ago, represent a unique group of channels that are regulated predominantly by the cellular metabolic state (32) . The function of the cardiac sarcolemmal K ATP channel (sarcK ATP ) from early on was associated with cardiac response to stress (32) , which was later confirmed by a number of studies. Opening of sarcK ATP channels during metabolic stress affects excitability and other membrane potential-related functions such as Ca 2ϩ loading, thus helping to maintain cellular homeostasis during cardiac challenge (13, 32) .
The physiological importance of the cardiac sarcK ATP channel became more apparent after generation of an animal model that lacks the sarcK ATP channel, the Kir6.2 knockout mouse (39) . The sarcK ATP channel-deficient mice were found to be less tolerant to different types of stress, with resulting abnormal cytosolic Ca 2ϩ handling, susceptibility to developing acute cardiac failure, and sudden cardiac death (24, 42, 44) . In contrast to the studies that suggest a cardioprotective function of sarcK ATP channel opening, there is also evidence that sarcK ATP channel activation may be harmful (5, 8, 16, 34) . For example, opening of the sarcK ATP channel was linked to a greater incidence of ventricular tachycardia and fibrillation (5, 8) . Moreover, a recent study suggests that inhibition of the cardiac sarcK ATP channel by HMR-1098 may lead to cardioprotection by affecting mitochondrial function (34) .
In humans the data are sparse, and only recently was a human disease linked to mutations within the cardiac sarcK ATP channel (4, 33) . Missense and frameshift mutations were identified within the SUR2A channel subunit in patients suffering from severe idiopathic dilated cardiomyopathy (4) . However, the mechanistic link between sarcK ATP channel dysfunction and heart failure is not elucidated. Although apoptosis was shown to play a critical role in the onset and progression of cardiovascular disease such as heart failure (26, 30) and myocardial infarction (22, 23) , up to now no studies have examined the role of sarcK ATP channels in apoptotic cell death.
Therefore, the goal of this study was to investigate the role of cardiac sarcK ATP channels in apoptotic cell death induced by oxidative stress in two types of cardiomyocytes: HL-1 cells and cultured neonatal cardiomyocytes. Additionally, we wanted to identify downstream intracellular consequences of cardiac sarcK ATP channel inhibition with emphasis on specific interaction between the sarcK ATP channel and the mitochondria.
were decapitated, the hearts were excised, and ventricular myocardium was minced in ADS buffer (in mM: 116 NaCl, 20 HEPES, 1 NaH 2PO4, 5.5 glucose, 5.4 KCl, and 0.8 MgSO4 with 3 mg/ml phenol red, pH 7.35) with 0.15 mg/ml collagenase (Worthington CLS II, Lakewood, NJ) and 0.52 mg/ml pancreatin (Life Technologies, Grand Island, NY) and incubated in a shaker at 37°C for 20 min at 100 rpm. Tissue pieces were allowed to settle, and the supernatant was collected, suspended in 1 ml of newborn calf serum (GIBCO, Carlsbad, CA), and centrifuged at 1,000 g for 6 min. The cell pellet was resuspended in 1 ml of newborn calf serum and stored at 37°C. The procedure was repeated until all tissue was digested. The cells were then resuspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with 17% medium 199, 10% horse serum, 5% FBS, 50 U/ml penicillin, 50 g/ml streptomycin, and 20 mm HEPES at pH 7.2 and preplated for 2 h on cell culture dishes to separate ventricular myocytes from the faster-attaching nonmyocytes. The ventricular myocytes in the supernatant were collected and plated on gelatincoated dishes and chamber slides. The neonatal cardiomyocytes were used for experiments after demonstrating confluence and rhythmic contractions (after 72 h).
Electrophysiology. For electrophysiological recordings of sarcK ATP channel activity, HL-1 and neonatal cardiomyocytes were lifted from culture dishes with 0.05% trypsin-0.53 mM EDTA, washed, and suspended in a Tyrode solution containing (in mM) 132 NaCl, 10 HEPES, 5 glucose, 5 KCl, 1 CaCl2, and 1.2 MgCl2 at pH 7.4. Single-channel activity was monitored from excised inside-out membrane patches at room temperature, as reported previously (38) . Briefly, the fire-polished borosilicate glass patch pipettes (Garner, Claremont, CA) had resistance of 7-10 M⍀ when filled with pipette solution. Single-channel currents were amplified with an EPC-7 amplifier, filtered at 0.5 kHz (low-pass Bessel 8-pole filter), digitized (Digidata 1322A), and analyzed with pCLAMP9 (Axon Instruments, Foster City, CA) and Origin7 (OriginLab, Northampton, MA). The channel open probability (Po) was determined as the fraction of time spent in the open state for recordings of 60-s duration. Recording solutions contained symmetrical concentrations of K ϩ . The pipette solution consisted of (in mM) 145 KCl, 0.5 CaCl2, 0.5 MgCl2, and 10 HEPES at pH 7.4, and the bath/internal solution consisted of 145 KCl, 0.5 MgCl2, 2 EGTA, and 10 HEPES with 50 M or 0 M K2ATP at pH 7.2. The sarcKATP channel inhibitor HMR-1098 (50 M, Aventis, Frankfurt, Germany) was applied in the internal solution.
Oxidative stress. HL-1 and neonatal cardiomyocytes were exposed to oxidative stress by replacement of regular DMEM from culture dishes with serum-and glucose-free DMEM containing H2O2 (200 M) and FeSO4 (50 M). The combination of H2O2 and FeSO4 produces hydroxyl radicals via the Fenton reaction (20) . After 20 min the H2O2-containing medium was replaced with DMEM containing glucose and 10% FBS. To assess the role of sarcKATP channels and mitochondrial Ca 2ϩ uptake, sarcKATP channel and mitochondrial Ca 2ϩ uniporter inhibitors HMR-1098 (50 M) and ruthenium red (2 M), respectively, were applied during and after oxidative stress. HMR-1098 was also administered 30 min before stress, followed by its washout before exposure to oxidative stress. For a negative control, cells were kept in DMEM containing 10% FBS with or without inhibitors and were not exposed to oxidative stress.
Laser-scanning confocal microscopy. HL-1 and neonatal cardiomyocytes were imaged with an inverted laser-scanning confocal microscope (Nikon Eclipse TE2000-U) with an ϫ20/1.4 oil-immersion objective (Nikon). Probes were excited at 488 nm with an argon laser, at 543 nm with a green HeNe laser, or at 633 nm with a red HeNe laser. The scanning speed was set to a minimal pixel dwell time of 1.92 s, and a set of filters (ND4 and ND8) were used in order to minimize dye bleaching and to protect the cells against possible photodamage. Each 512 ϫ 512-pixel image was averaged twice via software-selected repeated line scan mode to ameliorate signal-tonoise ratio. Data were analyzed off-line with Metamorph 6.1 software (Universal Imaging, West Chester, PA).
Assessment of apoptosis. HL-1 and neonatal cardiomyocytes (3 ϫ 10 5 cells/well at time of experiment) were grown on laminin-coated four-well LabTech II chamber slides (Nalgene Nunc, Naperville, IL) and exposed to oxidative stress as described above. Fifteen hours after oxidative stress, the cells were fixed in 1% paraformaldehyde, and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) was performed according to manufacturer's instructions with a commercial kit (Apoptag Fluorescein Direct In Situ Apoptosis Detection Kit, Chemicon International, Temecula, CA). Apoptotic nuclei stained with fluorescein isothiocyanate (TUNEL assay) were visualized by confocal microscopy. TO-PRO-3 was used to stain all nuclei. TUNEL-positive cells were counted, and the number of apoptotic cells was expressed as a percentage of the total number of cells (indicated by TO-PRO staining). For assessment of caspase-3 activation, both cell types were stained 3 h after stress with a CaspaTag caspase-3,7 in situ assay kit (Chemicon International, Temecula, CA) and sulforhodamine-labeled caspase-3-positive cells were imaged by confocal microscopy. In HL-1 cells, the activation of caspase-3 was expressed as the number of cells with active caspase-3,7 relative to the total number of cells, as indicated by TO-PRO-3 staining. In neonatal cardiomyocytes, the intensity of red sulforhodamine fluorescence, which is proportional to the activation of caspase-3,7, was expressed relative to the fluorescence intensity in the Control group (not exposed to oxidative stress), which was set at 100%. From each well, images from 10 random microscopic fields were taken at ϫ20 magnification.
Measurements of cytochrome c release. Three hours after oxidative stress HL-1 and neonatal cardiomyocytes were lifted from incubation plates (7 ϫ 10 6 cells/100-mm dish). To separate cytosolic and mitochondrial fractions, protein was extracted and differentially centrifuged by previously described methods (41) . To test for crosscontamination between the cytosolic and mitochondrial fractions, activities of lactate dehydrogenase and citrate synthase in both fractions were determined (41) . Lactate dehydrogenase activities for HL-1 cells (with neonatal cardiomyocytes in parenthesis) were 0.245 Ϯ 0.034 (0.275 Ϯ 0.064) and 0.005 Ϯ 0.002 (0.012 Ϯ 0.002) U/mg of protein in the cytosolic and mitochondrial fractions, respectively. The activities of citrate synthase were 0.818 Ϯ 0.077 (1.386 Ϯ 0.089) and 0.008 Ϯ 0.003 (0.012 Ϯ 0.004) U/mg of protein in the mitochondrial and cytosolic fractions, respectively. Therefore, cross-contamination between the cytosolic and mitochondrial fractions was considered negligible. Cytosolic and mitochondrial protein (25 g) were loaded on a polyacrylamide gel (Bio-Rad Readygel, Tris ⅐ HCl 4 -20%) and separated by electrophoresis (100 mV for 1 h). After transfer, the blots were blocked in Tris-buffered saline containing 5% nonfat dry milk and incubated with mouse cytochrome c immunoglobulin G1 antibody (BD Biosciences, San Jose, CA) at a dilution of 1:500. After being washed in Tris-buffered saline containing 0.05% Tween 20, the blot was incubated with a 1:10,000 dilution of horseradish peroxidaseconjugated secondary anti-mouse antibody (Santa Cruz Biotechnology, Santa Cruz, CA). Bands were visualized by chemiluminescence (Pierce Biotechnology, Rockford, IL) on radiographic film and analyzed by densitometry with the UN-SCAN-IT program (Silk Scientific, Orem, UT).
Monitoring of mitochondrial Ca 2ϩ during oxidative stress. HL-1 and neonatal cardiomyocytes grown on laminin-coated coverslips were incubated for 1 h at 37°C in culture medium containing 1 M rhod-2 AM (Invitrogen, Carlsbad, CA), a Ca 2ϩ -sensitive fluorescent indicator that is taken up preferentially by mitochondria. After loading, the cells were washed three times and left for an additional 30 min in culture medium to allow complete deesterification of the dye. Mitochondrial localization of rhod-2 was confirmed in each experiment by MitoTracker Green (Invitrogen). Coverslips were then transferred to a recording chamber on the stage of the confocal microscope and perfused with modified Tyrode solution containing (in mM) 132 NaCl, 10 HEPES, 5 glucose, 5 KCl, 1 CaCl2, and 1.2 MgCl2 (pH 7.4). Oxidative stress was induced by switching to a glucose-free Tyrode solution with added H2O2 (200 M) and FeSO4 (50 M). In the experiments with sarcKATP channel inhibition, HMR-1098 (50 M) was included in the perfusion solution. Rhod-2 fluorescence was detected at 590 nm every 60 s. Time lapse of mitochondrial Ca 2ϩ was evaluated by calculating relative rhod-2 fluorescence (100 ϫ F/F0, where F is measured rhod-2 fluorescence and F0 is that at beginning of experiment).
Assessment of Bcl-2 proapoptotic and antiapoptotic factors. After oxidative stress HL-1 cells were lifted from incubation plates, lysed, and homogenized. After electrophoresis (25 g protein/lane), transfer to the nitrocellulose membrane, and membrane blocking, the protein from cell homogenates was probed with rabbit polyclonal anti-Bcl-2 (Chemicon International, Temecula, CA) and rabbit polyclonal antiBad and mouse monoclonal anti-phospho (p)-Bad (both from Cell Signaling Technology, Beverly, MA) primary antibodies and the blotting procedure was finished as described above.
Statistical analysis. Results are expressed as means Ϯ SE. Data were analyzed with Origin7 software. Statistical analysis was performed by one-way analysis of variance with Bonferroni's post hoc test; n indicates the number of independent experiments in each group. Differences were considered significant when the P value was Ͻ0.05.
RESULTS

HMR-1098 inhibits sarcolemmal K ATP channels in HL-1 and neonatal cardiomyocytes.
To confirm the presence of functional sarcK ATP channels in HL-1 and neonatal cardiomyocytes and their sensitivity to HMR-1098, the single-channel activity was monitored from inside-out membrane patches in the presence and absence of a specific sarcK ATP channel inhibitor, HMR-1098. As shown in Fig. 1 , the currents recorded at Ϫ80 mV in the presence of 50 M intracellular ATP were inhibited by HMR-1098 in both HL-1 and neonatal cardiomyocytes. The channel opening was also blocked by 1-2 mM intracellular ATP (not shown), and recorded unitary current amplitude and unitary conductance were typical for the cardiac sarcK ATP channel.
Inhibition of sarcolemmal K ATP channel aggravates apoptotic cardiomyocyte death. To test whether inhibition of the sarcK ATP channel affects apoptotic cell death, HL-1 and neonatal cardiomyocytes were exposed to oxidative stress in the presence and absence of HMR-1098 ( Fig. 2A) . In HL-1 cells, exposure to stress increased the percentage of TUNEL-positive cells compared with control (19.9 Ϯ 1.7% in Stress group vs. 7.6 Ϯ 1.0% in Control group, Fig. 2B ). The percentage of apoptotic HL-1 cells was further increased in the presence of HMR-1098 (31.5 Ϯ 2.8% in StressϩHMR group, P Ͻ 0.05 compared with Stress group; n ϭ 5), while HMR-1098 pretreatment had no effect on stress-induced damage (20.9 Ϯ 3.3% in StressϩpHMR group). In the absence of stress, HMR-1098 did not affect apoptotic cell death (9.3 Ϯ 1.0% in HMR group). Application of the mitochondrial Ca 2ϩ uniporter inhibitor ruthenium red resulted in attenuation of stress-induced apoptosis in the presence of HMR-1098 (15.2 Ϯ 3.9% in StressϩRR group and 18.7 Ϯ 4.1 in StressϩHMRϩRR group, respectively, P Ͻ 0.05 vs. StressϩHMR; n ϭ 4). Similar results were found in neonatal cardiomyocytes, with 22.0 Ϯ 2.9% of TUNEL-positive cells in the Control group, 58.7 Ϯ 9% in the Stress group, 83.5 Ϯ 8.4% in the StressϩHMR group (P Ͻ 0.05 vs. Stress, n ϭ 5), and 15.5 Ϯ 1.9% in the HMR group. These findings were confirmed by the in situ caspase-3,7 assay (Fig. 3A) . As shown in Fig. 3B , activation of executioner caspases-3 and -7 was detected in a greater percentage of HL-1 cells when HMR-1098 was included during exposure to stress (6.3 Ϯ 1.4% in StressϩHMR group vs. 3.0 Ϯ 0.6% in Stress group, P Ͻ 0.05; n ϭ 5). Again, HMR-1098 alone did not affect the baseline levels of caspase-3,7 activation (0.4 Ϯ 0.02% and 0.4 Ϯ 0.1% in Control and HMR groups, respectively). Also, in neonatal cardiomyocytes oxidative stress in the presence of HMR-1098 caused greater activation of executioner caspases-3 and -7 compared with the cells exposed to stress alone (306 Ϯ 18% in Stress group vs. 403 Ϯ 23% in StressϩHMR group, P Ͻ 0.05; n ϭ 5).
Sarcolemmal K ATP channel inhibition potentiates involvement of mitochondrial death pathway. To investigate whether inhibition of the sarcK ATP channel modulates the mitochondrial death pathway, cytochrome c release from mitochondria to the cytosol was measured in both HL-1 and neonatal cardiomyocytes (Fig. 4, A and B, respectively) . Oxidative stress increased the cytochrome c release from mitochondria to cytosol relative to control. This increase was significantly augmented by administration of HMR-1098, suggesting that inhibition of the sarcK ATP channel during stress compromises mitochondrial integrity.
Augmentation of mitochondrial Ca 2ϩ loading during stress by sarcolemmal K ATP channel blockade. To test possible mechanism by which the sarcK ATP channel might affect mitochondrial homeostasis, changes in mitochondrial Ca 2ϩ content were monitored in both HL-1 and neonatal cardiomyocytes during exposure to stress in the presence and absence of HMR-1098. As shown in Fig. 5 , exposure to oxidative stress of HL-1 cells induced a gradual increase of rhod-2 fluorescence that at 50 min reached 110.1 Ϯ 5.7% of baseline. Rhod-2 fluorescence was increased significantly more when cardiomyocytes were treated with HMR-1098 during stress (139.9 Ϯ 10.0% of baseline, P Ͻ 0.05; n ϭ 6), indicating greater mitochondrial Ca 2ϩ loading. In neonatal cardiomyocytes oxidative stressinduced rise in rhod-2 fluorescence peaked at 118.1 Ϯ 3.3% and 137.7 Ϯ 2.9% in Stress and StressϩHMR groups, respectively (P Ͻ 0.05; n ϭ 5).
Inhibition of sarcolemmal K ATP channel has no effect on Bcl-2 and Bad. To investigate whether inhibition of sarcK ATP channel modulates some of the anti-and proapoptotic regulators, the levels of Bcl-2, Bad, and p-Bad were assessed. As demonstrated in Fig. 6A , exposure of HL-1 cells to stress with or without HMR-1098 had no effect on expression of Bcl-2. As seen in Fig. 6B , oxidative stress increased level of total Bad and p-Bad but did not affect the p-Bad-to-Bad ratio compared with control. The addition of HMR-1098 during stress did not induce further changes, indicating that inhibition of the sarcK ATP channel does not affect the amount of proapoptotic dephosphorylated Bad.
DISCUSSION
In the present study we demonstrated that inhibition of the sarcK ATP channel augments oxidative stress-induced apoptosis by affecting the mitochondrial death pathway. More specifically, a link between the sarcK ATP channel and mitochondrial Ca 2ϩ homeostasis during stress was identified. The protective role of sarcK ATP channels was hypothesized from the time of their discovery because of their ability to sense intracellular metabolic conditions (32) . This metabolic gating of the sarcK ATP channel is a result of the channel's molecular composition. The channel consists of an ATP- inhibited Kir6.2 subunit that forms the pore and a nucleotidebinding SUR2A modulatory subunit (19) . The channel opening under conditions of increased cardiac workload or ischemic challenge has a hyperpolarizing effect on the cell membrane, thus attenuating the cytosolic Ca 2ϩ overload and cellular damage (3, 44) .
Although previous studies have investigated the physiological role of the sarcK ATP channel and its contribution to the phenomenon of preconditioning, the involvement of the sarcK ATP channel in modulation of apoptotic cell death in the heart is unclear. In a study by Ichinose et al. (18) that investigated diazoxide-induced preconditioning in neonatal rat cardiomyocytes, HMR-1098 failed to abolish preconditioninginduced protection from oxidative stress-induced apoptosis and did not result in an increased rate of apoptosis. Conversely, in a similar experimental setting we found that inhibition of the sarcK ATP channel aggravates apoptotic cell death after stress, as evidenced by an increase in the number of TUNEL-positive cells as well as the increase in activation of executioner caspases-3 and -7. The disparity in the obtained results may be explained by a difference in timing of application of HMR-1098, since Ichinose et al. used the inhibitor only during the application of diazoxide, but not during the exposure to oxidative stress. Our previous study (28) demonstrated that the timing of administration of HMR-1098 is crucial, such that HMR-1098 has no effect on cell death if it is not applied during exposure to oxidative stress but rather only before the stress. In the present study, sarcK ATP channel inhibition did not affect apoptosis of cardiomyocytes in the absence of stress (HMR group) or when it was applied only before, but not during, stress (StressϩpHMR group). These results are in agreement with the widely accepted "dormant" nature of the sarcK ATP channel under conditions of metabolic abundance. Indeed, various studies using Kir6.2 knockout mice found that the phenotypic differences between the knockout and wild-type mice become apparent only when the mice are exposed to a certain type of stress (exercise, hypertension, ischemia-reperfusion) (25) .
Stressors that disturb cardiomyocyte homeostasis such as hypoxia, oxidative stress, and ischemia-reperfusion activate the mitochondrial death pathway. These noxious signals are transmitted to mitochondria either by directly affecting mitochondrial function or indirectly via proapoptotic members of the Bcl-2 family. Therefore, mitochondria play a central role in integrating cellular disturbances and initiating the mitochondrial death process (10) . Assessment of Bcl-2 level revealed that inhibition of the sarcK ATP channel does not affect its expression. Furthermore, administration of HMR-1098 alone also had no effect on expression of proapoptotic Bad. Since dephosphorylation of Fig. 3 . Inhibition of sarcKATP channel during oxidative stress increases activation of executioner caspases-3 and -7. A: overlay confocal microscopy images of To-Pro nuclear staining (blue) and sulforhodamine staining of active caspases-3, -7 (red) in HL-1 cells and neonatal cardiomyocytes. B: caspase activity was significantly higher in StressϩHMR group vs. Stress group (n ϭ 5; *P Ͻ 0.05), indicating greater activation of apoptotic machinery. HMR-1098 had no effect on caspase-3,7 activation in the absence of stress. Experimental groups are described in Fig. 2 .
Bad results in Bad activation and is stimulated by the rise in intracellular Ca 2ϩ , we also assessed whether inhibition of the sarcK ATP channel affects the amount of p-Bad. Measurements of p-Bad and assessment of the p-Bad-to-Bad ratio revealed no significant difference between groups exposed to stress in the presence and absence of HMR-1098. This suggests that the increase in apoptosis by sarcK ATP channel inhibition during stress is unlikely to be due to alterations in protein levels of the Bcl-2 family.
Mitochondria, besides being an essential ATP-producing organelle, are important regulators of cellular ionic homeostasis and play a major role in transmission and amplification of cellular death signals. During metabolic stress, mitochondria can act as buffers that attenuate the cytosolic Ca 2ϩ overload. However, if excessive, the mitochondrial Ca 2ϩ accumulation may lead to initiation of cell death (7). Mitochondrial Ca 2ϩ overload is a strong trigger of mitochondrial permeability transition pore opening, release of cytochrome c to the cytosol, and activation of the apoptotic machinery (17, 21) . Since sarcK ATP channel profoundly affects the cytosolic Ca 2ϩ loading during metabolic challenge (3, 44), we further hypothesized that the effects of sarcK ATP channel inhibition on apoptotic cell death are closely related to mitochondrial Ca 2ϩ . Our measurements of mitochondrial Ca 2ϩ during exposure of cardiomyocytes to oxidative stress revealed that mitochondrial Ca 2ϩ loading is significantly increased in the presence of sarcK ATP channel inhibitor. Since it is widely accepted that the downstream effects of the sarcK ATP channel opening are membrane hyperpolarization and resulting attenuation of intracellular entry of Ca 2ϩ during stress (3, 13), we conclude that the observed effects of HMR-1098 can be explained by an aggravated stress-induced cytosolic Ca 2ϩ overload in the presence of the inhibitor. The cytosolic Ca 2ϩ is taken up by the mitochondria (37, 43) , resulting in the rise of mitochondrial Ca 2ϩ and subsequent mitochondrial damage. In fact, the finding that ruthenium red, an inhibitor of mitochondrial Ca 2ϩ uniporter, attenuates the HMR-1098-induced potentiation of apoptosis supports this conclusion.
Mitochondrial Ca 2ϩ overload is a known trigger for cytochrome c release by affecting cytochrome c-cardiolipin interaction in the mitochondrial inner membrane (35) . Our measurements revealed that the apoptosis-triggering cytochrome c release to the cytosol after exposure to stress is greater in the presence of sarcK ATP channel inhibitor, further corroborating the finding of functional interaction between sarcK ATP channel and mitochondria. This study therefore offers new evidence for a connection between the activity of the sarcK ATP channel and the downstream function of mitochondria. The reverse, where the sarcK ATP channel activity is modulated by the mitochondria, was demonstrated in earlier studies. Since mitochondria produce most of the intracellular ATP and metabolize ADP, both major regulators of the sarcK ATP channel activity, it is apparent that mitochondrial function will inevitably affect the sarcK ATP channel (2) . This metabolic communication between sarcK ATP channel and different intracellular compartments including mitochondria was shown to be facilitated by the existence of an intracellular phosphotransfer network that overcomes diffusion barriers within the cell (11) . Therefore, a constant two-way interaction between the sarcK ATP channel and mitochondria helps to maintain cellular homeostasis during stress.
Interestingly, the ability of the sarcK ATP channel to affect mitochondrial function was investigated in a recent study by Pasdois et al. (34) . A transient inhibition of sarcK ATP before cardiac ischemia-reperfusion was found to induce preconditioning-like effects and protect the heart by affecting the mitochondria. These protective effects of HMR-1098 were suggested to be the result of a transient increase in intracellular Ca 2ϩ during application of sarcK ATP channel inhibitor. Since a transient moderate increase in cytosolic Ca 2ϩ before ischemiareperfusion is known to induce cardiac preconditioning (31), these findings are not counterintuitive. Therefore, it is possible that the sarcK ATP channel closing before cardiac stress induces a moderate Ca 2ϩ loading and Ca 2ϩ -induced preconditioning, while closing of the channel during stress results in excessive Ca 2ϩ loading leading to cell death. In both cases, mitochondria are affected through increases in cytosolic Ca 2ϩ . However, in our experimental setting, pretreatment with HMR-1098 followed by its washout before exposure to oxidative stress had no effect on cell damage. Differences in obtained results from our study and that of Pasdois et al. might possibly be explained by differences in the measured end point (apoptosis vs. infarct size), the experimental model (Langendorff-perfused heart vs. cell culture), or the type of stress. Furthermore, in a similar experimental setting (isolated heart exposed to global ischemiareperfusion), HMR-1098 pretreatment also had no effect on infarct size and contractile performance after ischemia-reperfusion (40) . The discrepancy in results from these studies using a very similar experimental approach is hard to explain and requires further investigation. However, it is obvious that, in order to observe the effect of sarcK ATP channel inhibitor, the sarcK ATP channel needs to be open. Since under normal stressfree conditions within the heart the sarcK ATP channels are expected to be closed, the question is why would the sarcK ATP channels open in preischemia conditions as suggested by data from the study of Pasdois et al.?
In our study we used the sarcK ATP channel inhibitor HMR-1098, which was previously demonstrated to inhibit the sarcK ATP channel currents in HL-1 cells (14) , an effect confirmed in the present study in both HL-1 and neonatal cardiomyocytes. One advantage of using HMR-1098 compared with other K ATP channel inhibitors is its selectivity for the sarcK ATP channels without affecting the K ATP channels in the mitochondria (36) .
Earlier studies using putative mitochondrial K ATP (mitoK ATP ) channel openers and inhibitors (diazoxide and 5-HD) already characterized the mitoK ATP channel as being protective against apoptotic cell death in cardiac myocytes (1) . The protective effects of mitoK ATP channel opening, with resulting mitochondrial K ϩ influx, include prevention against excessive mitochondrial Ca 2ϩ loading through mitochondrial membrane potential depolarization and consequently reduced driving force for the mitochondrial Ca 2ϩ entry (27, 29) . Therefore, the most likely mechanism of protection by activation of both sarcK ATP and mitoK ATP channels is related to attenuation of mitochondrial Ca 2ϩ overload and its fatal downstream outcome. Although HMR-1098 has been used in a great number of studies as a specific sarcK ATP channel blocker, potential other, yet unrecognized, targets might contribute to the observed effects of the present and previous studies. However, that is an inherent drawback of all pharmacological agents. On the other hand, the observed effects of the sarcK ATP blocker in the present study can have implications for the clinical setting in which sulfonylureas are commonly clinically used for glycemia regulation in patients suffering from Type 2 diabetes. Since a number of Type 2 diabetic patients taking sulfonylureas also suffer from ischemic heart disease, the safety of these drugs in this patient population has been questioned, but without a definite answer (6, 12, 15) . The present study, although performed with an in vitro model, provides insight into other intracellular effects of sulfonylureas in the heart.
From the results of this study we conclude that opening of the sarcK ATP channels plays an important role in prevention of cardiomyocyte apoptosis during metabolic stress. This effect is due to the specific interaction between the sarcK ATP channel and mitochondria, namely through sarcK ATP channel-induced modulation of mitochondrial Ca 2ϩ homeostasis and cytochrome c release.
